IMPACT OF SINGLE VERSUS DUAL ANTI PLATELET THERAPY ON EARLY OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE WIN-TAVI REGISTRY

Jaya Chandrasekhar,Alaide Chieffo,Anna Petronio,Samantha Sartori,Julinda Mehilli,Thierry Lefèvre,Patrizia Presbitero,Piera Capranzano,D. Tchetche,Alessandro Iadanza,Gennaro Sardella,Nicolas Van Mieghem,Emanuele Meliga,Nicolas Dumonteil,Chiara Fraccaro,Daniela Trabattoni,Ghada Mikhail,Samin K. Sharma,Maria Cruz Ferrer,Christoph Naber,Peter Kievit,Michela Faggioni,Usman Baber,Marie Claude Morice,Roxana Mehran

IMPACT OF SINGLE VERSUS DUAL ANTI PLATELET THERAPY ON EARLY OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE WIN-TAVI REGISTRY

2017

Background: The optimal antithrombotic strategy in patients undergoing transcatheter aortic valve replacement (TAVR) in undetermined. We sought to assess the incidence and outcomes of single (SAPT) vs. dual antiplatelet therapy (DAPT) post TAVR, excluding patients deemed to require anticoagulation

Keywords:

Aortic valve replacement
Internal medicine
Cardiology
Platelet
Medicine
anti platelet
Diabetes mellitus
Valve replacement
in patient
transcatheter aortic
Antithrombotic
Surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations